| Biomarker ID | 1893 |
| PMID | 30641210 |
| Year | 2019 |
| Biomarker | Interleukin 8 [SNP: rs1126647 TT vs AA + AT] |
| Biomarker Basis | Mutation Based |
| Biomolecule | Mutation |
| Source | Blood |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 2.14 (95% CI: 1.23-3.72) |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Benign Prostatic hyperplasia |
| Type of Biomarker | Diagnostic/Prognostic |
| Cohort | 530 individuals including 130 PCa patients, 200 BPH patients and 200 male controls were selected for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.02 |
| Method Used | ARMS-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |